BNET Industries
Bio-Reference Laboratories Inc. (BRLI) is in the Health Care Industry
- Revenue
- Oct 31 2007
- $250.4M
- Profit
- Oct 31 2007
- $13.9M
- Market Cap
- Nov 28 2008
- $307.0M
Latest News and Analysis
Bio-Reference Laboratories, Inc Q3 2008 Earnings Call Transcript
Question-and-Answer SessionOperator Operator instructions. And your first question comes from Robert Willoughby of Banc of America Securities. Please proceed. Aaron Gornin Hi. This is Aaron Gornin for Bob today. Just a question on the bad debt, can you comment on the current level and where you see that going...
Bio-Reference Laboratories, Inc. F2Q08 (Qtr End 4/30/08) Earnings Call Transcript
Question-and-Answer Session Operator Instructions Our first question comes from the line of Art Henderson with Jeffries & Company. Art Henderson - Jeffries & Company A couple of quick questions. As we think about the next couple of quarters and, Marc, I know you don’t give quarterly...
William Blair & Company Initiates Coverage of Bio-Reference Laboratories, Inc. With Outperform Rating
CHICAGO -- William Blair & Company initiated research coverage of Bio-Reference Laboratories, Inc. (Nasdaq:BRLI) ($27.97), the largest independent regional clinical laboratory focused on the New York area, with an Outperform rating and an Aggressive Growth company profile. Associate Analyst Amanda Murphy and Analyst John Kreger estimated that the company...
Bio-Reference Laboratories, Inc. to Speak at the Banc of America Securities HealthCare Conference
ELMWOOD PARK, N.J. -- Bio-Reference Laboratories, Inc. (NASDAQ - "BRLI") announced today that Marc D. Grodman M.D., President and Chief Executive Officer, is scheduled to speak at the Banc of America Securities HealthCare Conference on Tuesday, May 17, 2005, at The Four Seasons Hotel located in Las Vegas, NV. The...
Bio-Reference Laboratories, Inc. Presents At UBS Warburg Global Healthcare Conference
Health/Medical Writers BIOWIRE2K NEW YORK--BW HealthWire--Feb. 9, 2001 Company Continues to Experience Strong Organic Growth In a presentation at the UBS Warburg Global Healthcare Conference February 7, 2001, Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) told an audience of investors and industry analysts that the Company continues to...
Bio-Reference Laboratories, Inc. Presents At UBS Warburg Global Healthcare Conference
Health/Medical Writers BIOWIRE2K NEW YORK--BW HealthWire--Feb. 9, 2001 Company Continues to Experience Strong Organic Growth In a presentation at the UBS Warburg Global Healthcare Conference February 7, 2001, Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) told an audience of investors and industry analysts that the Company continues to...
Additional Resources
BioReference Laboratories, Inc to Speak at the 2008 Credit Suisse Phoenix Health Care Conference
ELMWOOD PARK, N.J. -- BioReference Laboratories, Inc (NASDAQ-"BRLI") announced today that Richard L. Faherty, Chief Information Officer, is scheduled to speak at the Credit Suisse Phoenix Health Care Conference on Thursday, November 13, 2008 at the Arizona Biltmore Resort located in Phoenix, Arizona. The BioReference Laboratories presentation is scheduled to...
BioReference Laboratories, Inc to Speak at the Oppenheimer 19th Annual Health Care Conference
ELMWOOD PARK, N.J. -- BioReference Laboratories, Inc. (NASDAQ-"BRLI") announced today that Marc D. Grodman M.D., President and Chief Executive Officer, is scheduled to speak at the Oppenheimer 19th Annual Health Care Conference on Tuesday, November 4, 2008, at The Waldorf Astoria Hotel located in New York, NY. The BioReference Laboratories...
Beacon Equity Issues Technical Trade Alerts on Medical Laboratories and Research Stocks: DGX, ERES, LH, PPDI, BRLI, CVD
DALLAS, Oct. 22 /PRNewswire/ -- BeaconEquity.com announces the availability of Trade Alerts on stocks making news today. Investors can view all of the daily trading notes for free by visiting: http://www.beaconequity.com/m Today's Trade Alerts include: Quest Diagnostics Inc. , eResearch Technology Inc. , Laboratory Corp....
BioReference Laboratories, Inc to Speak at the UBS Global Life Sciences Conference
ELMWOOD PARK, N.J. -- BioReference Laboratories, Inc (NASDAQ-"BRLI") announced today that Marc D. Grodman M.D., President and Chief Executive Officer, is scheduled to speak at the 2008 UBS Global Life Sciences Conference on Tuesday, September 23, 2008, at The Grand Hyatt Hotel located in New York, NY. The BioReference Laboratories...
Bio-Reference Laboratories, Inc. Announces Continued Strong Growth Led by Solid Gains in Its Esoteric Testing Divisions
18% Year over Year top line growth is fueled by GenPath and GeneDx ELMWOOD PARK, N.J. -- Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) (Except for Per Share Data or where otherwise noted, numbers are in thousands) announced that the Company recorded current quarter revenues of $77,776, the best ever...
BioReference Laboratories, Inc. Announces Earnings Date for Third Quarter for Fiscal Year 2008
ELMWOOD PARK, N.J. -- BioReference Laboratories, Inc. (NASDAQ: BRLI) announced today it plans to issue earnings results for the third quarter of fiscal 2008 before the open of market trading on Thursday, September 4, 2008. The Company's earnings conference call is to take place the same day at 10:30 a.m....
Bullmarket.com Offers Investment Opinion on Niche Medical Testing Companies
PRINCETON, N.J. -- BullMarket.com (http://www.bullmarket.com), an online investment newsletter focused on long-term growth and income-generating stocks, announced today that it has provided subscribers with a report on niche medical testing companies, including Genoptix (Nasdaq: GXDX), Bio-Reference Laboratories (Nasadaq: BRLI), and Nanosphere (Nasdaq: NSPH), among others. All paid and...
Bio-Reference Laboratories, Inc. Announces K-ras Testing Availability Through GenPath
ELMWOOD PARK, N.J. -- Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) announced today that K-ras mutation testing for patients with metastatic colorectal mCRC or non-small-cell lung NSCLC cancers will now be available through the Company's GenPath division. GenPath also offers many other tests as a part of their personalized medicine offering. Some...
Bio-Reference Laboratories, Inc. Announces Stock Buy-Back Plan
ELMWOOD PARK, N.J. -- Bio-Reference Laboratories, Inc. (NASDAQ: BRLI) announced today that its board of directors has approved a Stock Repurchase Program authorizing the repurchase of up to 1,000,000 shares of its Common Stock in the over-the-counter market at prevailing market prices through October 31, 2010. The board of directors...
BioReference Laboratories, Inc to Speak at the Jefferies Healthcare Conference
ELMWOOD PARK, N.J. -- BioReference Laboratories, Inc (NASDAQ - "BRLI") announced today that Marc D. Grodman M.D., President and Chief Executive Officer, is scheduled to speak at the Jefferies Conference on Tuesday, June 24, 2008, located in New York, NY. The BioReference Laboratories presentation is scheduled to begin at 8:00a.m.,...
BioReference Laboratories, Inc. Announces Earnings Date for Second Quarter for Fiscal Year 2008
ELMWOOD PARK, N.J. -- BioReference Laboratories, Inc. (NASDAQ: BRLI) announced today it plans to issue earnings results for the second quarter of fiscal 2008 before the open of market trading on Thursday, June 5, 2008. The Company's earnings conference call is to take place the same day at 10:30 a.m....
BioReference Laboratories, Inc. to Speak at the Bank of America Securities HealthCare Conference
ELMWOOD PARK, N.J. -- BioReference Laboratories, Inc. (NASDAQ:BRLI) announced today that Marc D. Grodman M.D., President and Chief Executive Officer, is scheduled to speak at the Bank of America Securities HealthCare Conference on Wednesday, May 14, 2008, at The Four Seasons Hotel located in Las Vegas, NV. The BioReference Laboratories...
BioReference Laboratories, Inc to Speak at the Eleventh Annual Lehman Brothers Global Healthcare Conference
ELMWOOD PARK, N.J. -- BioReference Laboratories, Inc (NASDAQ:BRLI) announced today that Richard L. Faherty, Chief Information Officer, is scheduled to speak at the Lehman Brothers Global Healthcare Conference on Tuesday, March 18th, 2008, at Loews Miami Beach Hotel, located in Miami, Florida. The BioReference Laboratories presentation is scheduled to begin...
Research and Markets: The Bio-Reference Laboratories, Inc Company Profile Is an Essential Source for Obtaining the Company's Key Data and Information
DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c85062) has announced the addition of "Bio-Reference Laboratories, Inc Company Profile" to their offering. The company profile examines the company's key business structure and operations, history and products. This is supplemented with relevant company facts, details on key executives and their biographies,...
- Next »
- page 1 of 1
- « Previous
Sort byClose
View by Content TypeClose
View Related Content by Tag Close
- Incorporated: 1981
- CEO: Dr. Marc D. Grodman
- Employees: 1,243
Bio-Reference Laboratories is a clinical laboratory servicing the New York metropolitan area. Co. provides laboratory testing services utilized by healthcare providers in the detection, diagnosis, evaluation, monitoring and treatment of diseases. In addition, Co. operates a clinical knowledge management service through its PSIMedica business unit, which uses customer data from laboratory results, pharmaceutical data and claims data to provide administrative and clinical decision support systems. Co. also operates a web-based connectivity system for laboratories and physicians through its CareEvolve subsidiary. Co.'s clients include doctors, employers, clinics and governmental units.
Key Competitors
Industry Transcripts by Seeking Alpha
-
Landauer, Inc. F4Q08 (Qtr End 9/30/08) Earnings Call Transcript
on Dec 02, 2008about LDR
-
Landauer, Inc. F4Q08 (Qtr End 9/30/08) Earnings Call Transcript
on Dec 02, 2008about LDR
-
Thermage Inc. Q3 2008 Earnings Call Transcript
on Dec 01, 2008about THRM
-
Allied Healthcare International Inc. F4Q08 (Qtr End 09/30/08) Earnings Call Transcript
on Nov 25, 2008about AHCI
-
StoneMor Partners, LP Q3 2008 (Quarter End 9/30/08) Earnings Call Transcript
on Nov 25, 2008about STON
Bio-Reference Laboratories Inc. Company Info
Board of Directors
Dr. Marc D. Grodman
Chairman
Mr. Howard Dubinett
Mr. Sam Singer
Mr. Joseph Benincasa
Mr. Harry Elias
Mr. Gary Lederman Esquire
Dr. John Roglieri
Contact Information
481 Edward H. Ross Drive
Elmwood Park, NJ
201 791-2600